| Report ID | 277242 |
| Drug Identification Number | 02240255 |
| Brand name | ADACEL |
| Common or Proper name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed |
| Company Name | Sanofi Vaccines Canada Ltd |
| Market Status | MARKETED |
| Active Ingredient(s) | TETANUS TOXOID FIMBRIAE TYPES 2 AND 3 PERTACTIN DIPHTHERIA TOXOID FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID |
| Strength(s) | 5LF 5MCG 3MCG 2LF 5MCG 2.5MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10 x 0.5 mL vials |
| Anatomical Therapeutical Chemical (ATC) code | J07AJ |
| Anatomical Therapeutical Chemical (ATC) description | BACTERIAL VACCINES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-02-03 |
| Estimated end date | 2026-02-20 |
| Actual end date | 2026-02-06 |
| Shortage status | Resolved |
| Updated date | 2026-02-10 |
| Company comments | Due to delays in the product release process. Supply planning is underway to continue to meet the Public market demand. Product not available for private market |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-10 | French | Compare |
| v3 | 2026-02-10 | English | Compare |
| v2 | 2026-02-04 | French | Compare |
| v1 | 2026-02-04 | English | Compare |
Showing 1 to 4 of 4